Amphastar Pharmaceuticals, Inc. Decrease in Unrecognized Tax Benefits is Reasonably Possible
Amphastar Pharmaceuticals, Inc. (AMPH) had Decrease in Unrecognized Tax Benefits is Reasonably Possible of $1.60 million as of 2018-12-31, per its 10-K filed 2021-03-15.
Discontinued › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:DecreaseInUnrecognizedTaxBenefitsIsReasonablyPossible · last filed 2021-03-15
- 2018-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $1.60M.
- 2017-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $1.90M.
- 2016-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $1.90M.
- 2015-12-31: Decrease in Unrecognized Tax Benefits is Reasonably Possible $1.90M.
| Period end | Decrease in Unrecognized Tax Benefits is Reasonably Possible |
|---|---|
| 2018-12-31 | $1.60M 10-K · filed 2021-03-15 |
| 2017-12-31 | $1.90M 10-K · filed 2018-03-14 |
| 2016-12-31 | $1.90M 10-K · filed 2017-03-15 |
| 2015-12-31 | $1.90M 10-K · filed 2016-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| MoonLake Immunotherapeutics (MLTX) | Switzerland | $1.031B | -5.43 |
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |